Advertisement

Topics

Karyopharm Reports Updated Phase IIb SADAL Data For Selinexor In Diffuse Large B-Cell Lymphoma At The 2017 European Hematology Association Annual Meeting

20:00 EDT 22 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Karyopharm Reports Updated Phase IIb SADAL Data For Selinexor In Diffuse Large B-Cell Lymphoma At The 2017 European Hematology Association Annual Meeting

NEXT ARTICLE

More From BioPortfolio on "Karyopharm Reports Updated Phase IIb SADAL Data For Selinexor In Diffuse Large B-Cell Lymphoma At The 2017 European Hematology Association Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement